1. Home
  2. IKT vs GAUZ Comparison

IKT vs GAUZ Comparison

Compare IKT & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • GAUZ
  • Stock Information
  • Founded
  • IKT 2008
  • GAUZ 2009
  • Country
  • IKT United States
  • GAUZ Israel
  • Employees
  • IKT N/A
  • GAUZ N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • GAUZ Industrial Machinery/Components
  • Sector
  • IKT Health Care
  • GAUZ Miscellaneous
  • Exchange
  • IKT Nasdaq
  • GAUZ Nasdaq
  • Market Cap
  • IKT 123.7M
  • GAUZ 102.0M
  • IPO Year
  • IKT 2020
  • GAUZ 2024
  • Fundamental
  • Price
  • IKT $1.53
  • GAUZ $6.18
  • Analyst Decision
  • IKT Buy
  • GAUZ Strong Buy
  • Analyst Count
  • IKT 2
  • GAUZ 3
  • Target Price
  • IKT $8.00
  • GAUZ $13.67
  • AVG Volume (30 Days)
  • IKT 96.5K
  • GAUZ 33.6K
  • Earning Date
  • IKT 11-13-2025
  • GAUZ 11-11-2025
  • Dividend Yield
  • IKT N/A
  • GAUZ N/A
  • EPS Growth
  • IKT N/A
  • GAUZ N/A
  • EPS
  • IKT N/A
  • GAUZ N/A
  • Revenue
  • IKT N/A
  • GAUZ $96,810,000.00
  • Revenue This Year
  • IKT N/A
  • GAUZ $22.59
  • Revenue Next Year
  • IKT N/A
  • GAUZ $41.48
  • P/E Ratio
  • IKT N/A
  • GAUZ N/A
  • Revenue Growth
  • IKT N/A
  • GAUZ 7.87
  • 52 Week Low
  • IKT $1.42
  • GAUZ $4.54
  • 52 Week High
  • IKT $4.20
  • GAUZ $13.00
  • Technical
  • Relative Strength Index (RSI)
  • IKT 41.85
  • GAUZ 47.06
  • Support Level
  • IKT $1.53
  • GAUZ $6.12
  • Resistance Level
  • IKT $1.67
  • GAUZ $6.75
  • Average True Range (ATR)
  • IKT 0.11
  • GAUZ 0.44
  • MACD
  • IKT -0.00
  • GAUZ -0.05
  • Stochastic Oscillator
  • IKT 19.64
  • GAUZ 25.37

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

Share on Social Networks: